Giới thiệu công ty
- Mã cổ phiếu
- AMGN
- Mã ISIN
- US0311621009
- Tiền tệ
- US Dollar (USD)
- Ngày IPO
- 1983-06-17

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease;...